These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1089404)

  • 21. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transporter effects on cell permeability in drug delivery.
    Mandal A; Agrahari V; Khurana V; Pal D; Mitra AK
    Expert Opin Drug Deliv; 2017 Mar; 14(3):385-401. PubMed ID: 27449574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting permeability coefficient in ADMET evaluation by using different membranes-interaction QSAR.
    Liu J; Li Y; Pan D; Hopfinger AJ
    Int J Pharm; 2005 Nov; 304(1-2):115-23. PubMed ID: 16182478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eyes on new product development.
    Novack GD
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):611. PubMed ID: 23981251
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA gathers information for plans to regulate nanoscale drugs.
    Lavine G
    Am J Health Syst Pharm; 2008 Nov; 65(21):1988, 1990. PubMed ID: 18945848
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogeriatrics.
    Pucino F; Beck CL; Seifert RL; Strommen GL; Sheldon PA; Silbergleit IL
    Pharmacotherapy; 1985; 5(6):314-26. PubMed ID: 3909117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular injection of drugs.
    Greenblatt DJ; Koch-Weser J
    N Engl J Med; 1976 Sep; 295(10):542-6. PubMed ID: 950960
    [No Abstract]   [Full Text] [Related]  

  • 28. Challenges and obstacles of ocular pharmacokinetics and drug delivery.
    Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1131-5. PubMed ID: 17097758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic transfer functions and generalized clearances.
    Siegel RA
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):511-21. PubMed ID: 3806373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane systems: theoretical aspects.
    Smith KL; Lonsdale HK
    Methods Enzymol; 1985; 112():495-504. PubMed ID: 4046861
    [No Abstract]   [Full Text] [Related]  

  • 31. Ocular drug delivery.
    Goepferich A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):157. PubMed ID: 26004820
    [No Abstract]   [Full Text] [Related]  

  • 32. [Liposomes as ocular drug delivery systems].
    Carvalho EL; De la Fuente M; Seijo Rey B
    Arch Soc Esp Oftalmol; 2004 Apr; 79(4):151-2. PubMed ID: 15124069
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of drug release kinetics from degradable polymeric devices.
    Fischel-Ghodsian F; Newton JM
    J Drug Target; 1993; 1(1):51-7. PubMed ID: 8069544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Legal problems in psychiatric drug prescription.
    Appleton WS
    Am J Psychiatry; 1968 Jan; 124(7):877-82. PubMed ID: 5688683
    [No Abstract]   [Full Text] [Related]  

  • 35. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2021; 37(6):319-320. PubMed ID: 34129379
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory aspects of devices.
    Wachtel H
    Int J Pharm; 2012 Oct; 435(2):142-4. PubMed ID: 22883700
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of drug concentrations in body fluids; possibilities and limitations. I. Determination of plasma levels as a basis for understanding].
    Ariëns EJ; Simonis AM
    Ned Tijdschr Geneeskd; 1980 Jul; 124(29):1192-201. PubMed ID: 6997756
    [No Abstract]   [Full Text] [Related]  

  • 38. A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.
    Rivers HM; Ray Chaudhuri S; Shah JC; Mittal S
    Pharm Res; 2015 Sep; 32(9):2814-23. PubMed ID: 26055402
    [No Abstract]   [Full Text] [Related]  

  • 39. Model of transient drug diffusion across cornea.
    Zhang W; Prausnitz MR; Edwards A
    J Control Release; 2004 Sep; 99(2):241-58. PubMed ID: 15380634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theory and practice of prodrug kinetics.
    Notari RE
    Methods Enzymol; 1985; 112():309-23. PubMed ID: 4046852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.